CLEVELAND, July 18, 2018 /PRNewswire/ -- The Harrington Discovery Institute at University Hospitals in Cleveland,
Up to three Gund-Harrington Scholar awards will be made in 2019. Award recipients will receive:
Important submission dates:
For more information or to apply, please visit HarringtonDiscovery.org/Gund.
Foundation Fighting Blindness Foundation Fighting Blindness is the world's leading private research funding source for retinal degenerative diseases such as retinitis pigmentosa, Stargardt disease, Usher syndrome, and age-related macular degeneration. The nonprofit was co-founded by Gordon and Lulie Gund and Ben Berman in 1971 and has raised more than $725 million toward its mission. FFB has a broad network and deep domain expertise in inherited retinal diseases, a set of programs for funding discoveries and advancing them toward clinical studies, and a robust pipeline of funded projects that represent new therapeutic opportunities. The Foundation is funding startup companies and for-profit initiatives through its establishment of the Clinical Research Institute (the CRI), a not-for-profit subsidiary, which can partner to provide substantial later-stage funding for high-potential projects. The Foundation is supporting several clinical trials, and many additional gene and stem cell-based human studies could begin in the next several years. For more information, please visit fightblindness.org.
Harrington Discovery Institute The Harrington Discovery Institute at University Hospitals in Cleveland, OH – part of The Harrington Project for Discovery & Development – aims to advance medicine and society by enabling our nation's most inventive scientists to turn their discoveries into medicines that improve human health. The institute was created in 2012 with a $50 million founding gift from the Harrington family and instantiates the commitment they share with University Hospitals to a Vision for a 'Better World'.
The Harrington Project for Discovery & DevelopmentThe Harrington Project for Discovery & Development (The Harrington Project), founded in late February 2012 by the Harrington Family and University Hospitals of Cleveland, is a $300 million national initiative built to bridge the translational valley of death. It includes the Harrington Discovery Institute and BioMotiv, a for-profit, mission-aligned drug development company that accelerates early discovery into pharma pipelines.
For more information about The Harrington Project and the Harrington Discovery Institute, visit: HarringtonDiscovery.org.
University HospitalsTo learn more about UH, please visit UHhospitals.org.
View original content:http://www.prnewswire.com/news-releases/call-for-applications-gund-harrington-grant-award-to-fight-blindness-300682997.html
SOURCE Harrington Discovery Institute
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All